GLP-1s are powerful medications intended for the treatment of chronic metabolic disease not short-term cosmetic fixes
GLP-1 receptor agonists including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have produced some of the most dramatic weight loss outcomes in the history of pharmacology
Some clinicians may consider GLP-1 medications in weight management based on individual factors, but eligibility and appropriateness must be determined by a licensed provider
A provider with 50 five-star reviews is less informative than one with 4,000 reviews averaging 4.2 stars
There are also Ozempic alternatives that quiet food noise naturally, and some patients are having success with microdosing Ozempic to cut down on costs (and side effects)
We have often seen that even after weight loss, many patients are unhappy with stubborn fat in areas like the stomach or buttocks, explains GMS Clinical Director Amanda Pucci